Tirofiban-induced acute profound thrombocytopenia after primary angioplasty.

Autor: Dursunoglu, Dursun, Taşköylü, Özgür, Gür, Sükrü, Sari, İsmail
Zdroj: Asian Cardiovascular & Thoracic Annals; Feb2013, Vol. 21 Issue 1, p74-76, 3p
Abstrakt: Glycoprotein IIb/IIIa inhibitors are used in the acute coronary syndromes and percutaneous coronary intervention as antiplatelet agents. However, these agents induce thrombocytopenia in approximately 1% to 5% of patients, and may lead to bleeding complications. Abciximab is associated with higher incidence of thrombocytopenia than eptifibatide and tirofiban. We describe a case of acute profound thrombocytopenia due to on tirofiban treatment in a patient who underwent primary angioplasty. [ABSTRACT FROM PUBLISHER]
Databáze: Complementary Index